Clinical trials recruiting for Locally Advanced Triple-Negative Breast Carcinoma
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Pembrolizumab | 4 |
| BET Bromodomain Inhibitor ZEN-3694 | 1 |
| Cyclophosphamide | 1 |
| Ipilimumab | 1 |
| Nab-paclitaxel | 1 |
| Neoantigen Peptide Vaccine | 1 |
| Sargramostim | 1 |
| Vaccine Therapy | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| New York | 2 |
| Florida | 1 |
| Georgia | 1 |
| Massachusetts | 1 |
| New Jersey | 1 |
| Ohio | 1 |
| Tennessee | 1 |
Top cities
Self-screener
Recruiting trials
- A Study of Pembrolizumab and Ablation (Cryoablation or Histotripsy) in People With Breast Cancer
- Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
- Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer
- Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast Cancer
Related conditions
Trials recruiting for Locally Advanced Triple-Negative Breast Carcinoma often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Locally Advanced Triple-Negative Breast Carcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.